Pharmacoeconomics Market Research Reports
From €4602EUR$5,000USD£3,982GBP
From €4602EUR$5,000USD£3,982GBP
From €4602EUR$5,000USD£3,982GBP
From €345EUR$375USD£299GBP
From €884EUR$960USD£765GBP
From €2757EUR$2,995USD£2,385GBP
From €548EUR$595USD£474GBP
From €884EUR$960USD£765GBP
From €345EUR$375USD£299GBP
From €4556EUR$4,950USD£3,942GBP
From €4565EUR$4,960USD£3,950GBP
From €2757EUR$2,995USD£2,385GBP
From €6903EUR$7,500USD£5,973GBP
From €545EUR$634USD£488GBP
From €545EUR$634USD£488GBP
From €545EUR$634USD£488GBP
From €545EUR$634USD£488GBP
The term Pharmaeconomics describes a scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. It is not just an effective way to analyse and measure the pharmaceutical industry, but also for industry players to gain a competitive advantage and new market entrants to accurately identify where the best commercial opportunities lie.
Whether by cost-minimization analysis, cost-benefit analysis, cost-effectiveness analysis or cost-utility analysis, the reports, books, and journals listed under in Research and Markets’ Pharmaeconomics category enable buyers to more accurately apply pharmaeconomics, and to study case histories of these principles put into effective real life action by pharmaceutical companies.
From academic books that introduce students to a set of analytical tools of economic evaluations and their applications in the health sector to special reports covering every aspect of the drug development pipeline (from production and pricing to reviewing portfolios), you will find in this section the information resource that you need. Show Less Read more
